There simply are NO realistic competing providers/solutions, so I suspect Singhgu won't be able to answer.
Drysol and Qbrexza don't work well at all. SB trials showed Sofdra's superiority to those products.
So if patients don't want to use the best-performing topical treatment on the market (i.e. Sofdra), they'll have to look to getting their underarms burnt with MiraDry, or 30 Botox injections to each armpit, or surgery! And even then, the reviews for those products certainly don't have people racing out to use them (and the reviews for surgery are atrocious)!
Sofdra it is, and Sofdra it will be!
BOT - Anything but charting, page-8984
Add BOT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
37.0¢ |
Change
-0.010(2.63%) |
Mkt cap ! $669.7M | |||
| Open | High | Low | Value | Volume |
| 37.0¢ | 37.5¢ | 36.0¢ | $3.051M | 8.277M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 465836 | 37.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 37.5¢ | 301865 | 3 |
View Market Depth
| Last trade - 16.10pm 19/07/2024 (20 minute delay) ? |
| BOT (ASX) Chart |